Bio-Rad Labs (BIO) Misses Q4 EPS by 16c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $356.26 --0%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $3.31, $0.16 worse than the analyst estimate of $3.47. Revenue for the quarter came in at $730.3 million versus the consensus estimate of $747.26 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
